NFKB1 and neoplasm: Previous studies have demonstrated that activation of TLR4 could lead to its dimerization, activation of the MyD88-dependent or -independent NF-κB signaling pathway, thus promoting tumor growth and invasion by regulating tumor immune and inflammatory response (Płóciennikowska et al., 2015; Chen et al., 2018).